金城医药：关于转让药品生产技术及上市许可持有人权益的公告

Core Viewpoint - Jincheng Pharmaceutical announced the transfer of production technology and licensing rights for "Progesterone Vaginal Soft Capsules" to Haimeini (Shanghai) Pharmaceutical Technology Co., Ltd. for a total fee of 50 million RMB [2] Group 1 - Jincheng Pharmaceutical's wholly-owned subsidiary, Beijing Jincheng Taier Pharmaceutical Co., Ltd., is involved in the transaction [2] - The product being transferred is "Progesterone Vaginal Soft Capsules" (brand name: Langyigeng Baifen®), for which Jincheng Taier holds the drug approval number [2] - The total transaction fee, including tax, is set at 50 million RMB [2]